# Lexeo Therapeutics, Inc.: Form 8-K, filed Sep 22, 2026

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2026-09-22
- Accepted by EDGAR: Sep 22, 2026, 07:08 ET
- Period: 2026-09-16
- Accession: 0001193125-26-397221
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000119312526397221/lxeo-20260916.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000119312526397221/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000119312526397221/lxeo-20260916.htm

Filed Sep 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-397221. Last ingested by Listed: Nov 5, 2026, 11:18 ET. No prices; not investment advice.